A Study of Vismodegib With Surgery in Participants With Previously Untreated Basal Cell Carcinoma

Summary

This randomized, double-blind, placebo-controlled study will assess the efficacy and safety of vismodegib with surgery in participants with basal cell carcinoma.

Timeline

Start

2014-01-23

Primary completion

2016-01-26

Completion

2016-01-26

Drugs

Indications